Acasti Pharma Price on December 2, 2024
| ACSTDelisted Stock | USD 3.37 0.01 0.30% |
If you're considering investing in Acasti Stock, it is important to understand the factors that can impact its price. As of today, the current price of Acasti Pharma stands at 3.37, as last reported on the 3rd of December, with the highest price reaching 3.45 and the lowest price hitting 3.20 during the day. Acasti Pharma appears to be very risky, given 3 months investment horizon. Acasti Pharma secures Sharpe Ratio (or Efficiency) of 0.17, which signifies that the company had a 0.17% return per unit of standard deviation over the last 3 months. By analyzing Acasti Pharma's technical indicators, you can evaluate if the expected return of 0.89% is justified by implied risk. Please makes use of Acasti Pharma's mean deviation of 3.0, and Risk Adjusted Performance of 0.0702 to double-check if our risk estimates are consistent with your expectations.
Acasti Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Acasti |
Sharpe Ratio = 0.1715
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ACST | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.21 actual daily | 46 54% of assets are more volatile |
Expected Return
| 0.89 actual daily | 17 83% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Acasti Pharma is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Acasti Pharma by adding it to a well-diversified portfolio.
Acasti Pharma Main Headline on 25th of October 2024
Acasti Pharma changes name to Grace Therapeutics by seekingalpha.com
Acasti Pharma changes its name to Grace Therapeutics, set to trade as GRCE on Nasdaq starting October 28, 2024.
Acasti Pharma Valuation on December 2, 2024
It is possible to determine the worth of Acasti Pharma on a given historical date. On December 2, 2024 Acasti was worth 3.38 at the beginning of the trading date compared to the closed value of 3.37. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Acasti Pharma stock. Still, in general, we apply an absolute valuation method to find Acasti Pharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Acasti Pharma where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Acasti Pharma's related companies.
| Open | High | Low | Close | Volume | |
| 3.54 | 3.58 | 3.30 | 3.40 | 118,986 | |
10/25/2024 | 3.38 | 3.45 | 3.20 | 3.37 | 27,805 |
| 3.38 | 3.45 | 3.20 | 3.37 | 0.00 |
| Backtest Acasti Pharma | | | Acasti Pharma History | | | Acasti Pharma Valuation | Previous | Next |
Acasti Pharma Trading Date Momentum on December 2, 2024
| On December 03 2024 Acasti Pharma was traded for 3.37 at the closing time. The top price for the day was 3.45 and the lowest listed price was 3.20 . There was no trading activity during the period 0.0. Lack of trading volume on December 3, 2024 did not affect price variability. The overall trading delta against the current closing price is 0.30% . |
Acasti Pharma Fundamentals Correlations and Trends
By evaluating Acasti Pharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Acasti Pharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Acasti financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Acasti Pharma Stock history
Acasti Pharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Acasti is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Acasti Pharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Acasti Pharma stock prices may prove useful in developing a viable investing in Acasti Pharma
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Acasti Pharma Stock Technical Analysis
Acasti Pharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Acasti Pharma Period Price Range
Low | December 3, 2024
| High |
0.00 | 0.00 |
Acasti Pharma cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Acasti Pharma December 3, 2024 Market Strength
Market strength indicators help investors to evaluate how Acasti Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Acasti Pharma shares will generate the highest return on investment. By undertsting and applying Acasti Pharma stock market strength indicators, traders can identify Acasti Pharma entry and exit signals to maximize returns
Acasti Pharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Acasti Pharma's price direction in advance. Along with the technical and fundamental analysis of Acasti Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Acasti to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0702 | |||
| Jensen Alpha | 0.3678 | |||
| Total Risk Alpha | (0.31) | |||
| Sortino Ratio | 0.0743 | |||
| Treynor Ratio | (1.72) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in Acasti Stock
If you are still planning to invest in Acasti Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Acasti Pharma's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stocks Directory Find actively traded stocks across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |